Philip H Abbosh

7PUBLICATIONS
49CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Women's studies (incl. girls' studies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 29, 2026
Association Between Antibiotic Therapy and Treatment Effectiveness in Patients With Renal Cell Carcinoma Receiving Immune Checkpoint Inhibitors or Tyrosine Kinase Inhibitors.

|Apr 10, 2025
Gender Disparities in Citations and Altmetric Attention Score in Oncology.

Rebecca A Campbell, Emma Helstrom, Lauren Chew

|Dec 16, 2024
Phase II Trial of Risk-Enabled Therapy After Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer (RETAIN 1).

Daniel M Geynisman, Philip H Abbosh, Eric Ross

|Aug 16, 2024
Identification and Validation of Prognostic Model for Tumor Microenvironment-Associated Genes in Bladder Cancer Based on Single-Cell RNA Sequencing Data Sets.

Imran Safder, Henkel Valentine, Nicole Uzzo

|Jul 16, 2024
Association of circulating tumor DNA with patient prognosis in surgically resected renal cell carcinoma.

Andres F Correa, Ekaterina Kalashnikova, Hsin-Ta Wu

|Jun 12, 2024
Urine Biopsy as Dynamic Biomarker to Enhance Clinical Staging of Bladder Cancer in Radical Cystectomy Candidates.

Uttam Satyal, Henkel Valentine, David Liu

Pageof 2

Frequent Collaborators

5 joint publications

Elizabeth R Plimack

5 joint publications

Laura Bukavina

3 joint publications

Henkel Valentine

3 joint publications

Andres F Correa